D
Phathom Pharmaceuticals, Inc. PHAT
$4.41 $0.194.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 4,249.56% -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 4,249.56% -- -- -- --
Cost of Revenue 2,184.43% -- -- -- --
Gross Profit 4,919.22% -- -- -- --
SG&A Expenses 34.54% 225.27% 300.65% 233.42% 85.68%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 26.25% 144.39% 166.94% 138.94% 51.27%
Operating Income 14.97% -98.54% -143.84% -132.58% -49.81%
Income Before Tax 6.43% -97.90% -123.23% -119.10% -44.55%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 6.43% -97.90% -123.23% -119.10% -44.55%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 6.43% -97.90% -123.23% -119.10% -44.55%
EBIT 14.97% -98.54% -143.84% -132.58% -49.81%
EBITDA 15.02% -98.67% -144.17% -133.00% -49.95%
EPS Basic 24.55% -73.87% -84.89% -58.98% -4.23%
Normalized Basic EPS 24.54% -73.87% -84.88% -58.98% -4.23%
EPS Diluted 24.55% -73.87% -84.89% -58.98% -4.23%
Normalized Diluted EPS 24.54% -73.87% -84.88% -58.98% -4.23%
Average Basic Shares Outstanding 24.00% 13.82% 20.74% 37.82% 38.69%
Average Diluted Shares Outstanding 24.00% 13.82% 20.74% 37.82% 38.69%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings